Robert H. Dworkin

Active 1984–2025

Also published as
Robert H Dworkin
149
Papers
47,915
Citations
91
h-index
145
i10-index

Citations

Citations per year for Robert H. Dworkin1985: 4 citations1986: 5 citations1987: 9 citations1988: 8 citations1989: 8 citations1990: 6 citations1991: 16 citations1992: 20 citations1993: 23 citations1994: 24 citations1995: 17 citations1996: 27 citations1997: 33 citations1998: 22 citations1999: 31 citations2000: 45 citations2001: 40 citations2002: 32 citations2003: 54 citations2004: 89 citations2005: 146 citations2006: 212 citations2007: 240 citations2008: 298 citations2009: 366 citations2010: 420 citations2011: 352 citations2012: 315 citations2013: 380 citations2014: 378 citations2015: 448 citations2016: 437 citations2017: 454 citations2018: 404 citations2019: 1,578 citations2020: 1,564 citations2021: 1,461 citations2022: 990 citations2023: 724 citations2024: 1,192 citations2025: 480 citations2026: 14 citations

Citation sources

Countries

World map of the countries and regions citing this authorUnited States: 4,128 citing papers, 28.1% of this breakdownUnited Kingdom: 1,431 citing papers, 9.8% of this breakdownCanada: 920 citing papers, 6.3% of this breakdownGermany: 767 citing papers, 5.2% of this breakdownChina: 709 citing papers, 4.8% of this breakdownAustralia: 655 citing papers, 4.5% of this breakdownItaly: 517 citing papers, 3.5% of this breakdownNetherlands: 438 citing papers, 3% of this breakdownFrance: 422 citing papers, 2.9% of this breakdownSpain: 389 citing papers, 2.7% of this breakdownDenmark: 357 citing papers, 2.4% of this breakdownSweden: 305 citing papers, 2.1% of this breakdown
0%28.1%Other 24.7%

Fields

  • Medicine81.6%
  • Neuroscience5.3%
  • Psychology4.1%
  • Biochemistry, Genetics and Molecular Biology3.3%
  • Health Professions1.7%
  • Pharmacology, Toxicology and Pharmaceutics0.6%
  • Other3.4%

Topics

  • Pain Mechanisms and Treatments12.1%
  • Musculoskeletal pain and rehabilitation7.9%
  • Pain Management and Opioid Use4.1%
  • Pain Management and Treatment2.8%
  • Fibromyalgia and Chronic Fatigue Syndrome Research2.6%
  • Pain Management and Placebo Effect2.5%
  • Other68%

Coauthors

All papers

Open in search
  1. Pharmacotherapy for neuropathic pain in adults: a systematic review and meta-analysis

    Authors: , , , , , , , , , , , , , , , , , , , - The Lancet Neurology 2015 cited by 3,882

  2. Neuropathic pain

    Authors: , , , , , , , , , , , , , , - Nature Reviews Disease Primers 2017 cited by 2,015

  3. Core outcome measures for chronic pain clinical trials: IMMPACT recommendations

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Joseph Stauffer, Wendy M. Stein, Jane Tollett, Joachim Wernicke, James Witter - Pain 2004 cited by 3,726

  4. Interpreting the Clinical Importance of Treatment Outcomes in Chronic Pain Clinical Trials: IMMPACT Recommendations

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Christine Rauschkolb, Dennis A. Revicki, Margaret Rothman, Kenneth E. Schmader, Brett R. Stacey, Joseph Stauffer, Thorsten von Stein, Richard E. White, James Witter, Stojan Zavisic - Journal of Pain 2007 cited by 3,405

  5. Core outcome domains for chronic pain clinical trials: IMMPACT recommendations

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , - Pain 2003 cited by 3,501

  6. The Role of Psychosocial Processes in the Development and Maintenance of Chronic Pain

    Authors: , , , , - Journal of Pain 2016 cited by 918

  7. Interpretation of chronic pain clinical trial outcomes: IMMPACT recommended considerations

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Jasvinder A. Singh, Ilona Steigerwald, Vibeke Strand, Leslie Tive, Jeffrey Tobias, Ajay D. Wasan, Hilary Wilson - Pain 2020 cited by 181

  8. Prevention and Management of Chemotherapy-Induced Peripheral Neuropathy in Survivors of Adult Cancers: American Society of Clinical Oncology Clinical Practice Guideline

    Authors: , , , , , , , , , , , , , , , , , - Journal of Clinical Oncology 2014 cited by 1,220

  9. Identifying important outcome domains for chronic pain clinical trials: An IMMPACT survey of people with pain

    Authors: , , , , , , , , , , , - Pain 2007 cited by 525

  10. The Prevalence of Chronic Pain in United States Adults: Results of an Internet-Based Survey

    Authors: , , , , - Journal of Pain 2010 cited by 1,256

  11. Interpreting the clinical importance of group differences in chronic pain clinical trials: IMMPACT recommendations

    Authors: , , , , , , , , , , , - Pain 2009 cited by 659

  12. Recommendations for the Management of Herpes Zoster

    Authors: , , , , , , , , , , , , , , , , , , , , , , - Clinical Infectious Diseases 2006 cited by 845

  13. Pharmacologic management of neuropathic pain: Evidence-based recommendations

    Authors: , , , , , , , , , , , , , , , - Pain 2007 cited by 2,121

  14. Patient phenotyping in clinical trials of chronic pain treatments: IMMPACT recommendations

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Shannon M. Smith, Jeffrey Tobias, Tina Tockarshewsky, Christin Veasley, Mark Versavel, Ajay D. Wasan, Warren Wen, David Yarnitsky - PAIN Reports 2016 cited by 399

  15. Interventional management of neuropathic pain: NeuPSIG recommendations

    Authors: , , , , , , , , , , , , , - Pain 2013 cited by 455

  16. The Prevalence of Psychiatric and Chronic Pain Comorbidities in Fibromyalgia: an ACTTION systematic review

    Authors: , , , , , , , , , - Seminars in Arthritis and Rheumatism 2020 cited by 199

  17. Transition to chronic pain: opportunities for novel therapeutics

    Authors: , , , , , , , , , , , , , , , , - Nature reviews. Neuroscience 2018 cited by 162

  18. Optimizing and Accelerating the Development of Precision Pain Treatments for Chronic Pain: IMMPACT Review and Recommendations

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Daniel Vardeh, Gary A. Walco, Ajay D. Wasan, Ursula Wesselmann - Journal of Pain 2022 cited by 93

  19. Recommendations for the Pharmacological Management of Neuropathic Pain: An Overview and Literature Update

    Authors: , , , , , , , , , , , , , , , , , , , , , - Mayo Clinic Proceedings 2010 cited by 1,323

  20. Development and initial validation of an expanded and revised version of the Short-form McGill Pain Questionnaire (SF-MPQ-2)

    Authors: , , , , , , , , , , , , , , - Pain 2009 cited by 753

  21. Pain associated with multiple sclerosis: Systematic review and proposed classification

    Authors: , , , , - Pain 2007 cited by 496

  22. The prevalence of comorbid chronic pain conditions among patients with temporomandibular disorders

    Authors: , , , , , , , , , , - The Journal of the American Dental Association 2021 cited by 80

  23. Advances in Neuropathic Pain

    Authors: , , , , , , , , , , , , , , , , , , , , - Archives of Neurology 2003 cited by 1,209

  24. Neuropathic pain clinical trials: factors associated with decreases in estimated drug efficacy

    Authors: , , , , , , , , , , , , , , , - Pain 2018 cited by 143